US Stock MarketDetailed Quotes

RUBY Rubius Therapeutics

Watchlist

0.057000
0.0000000.00%

15min DelayClose Dec 29 16:00 ET

5.16MMarket Cap-28P/E (TTM)

Rubius Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-34.62%127.25M

-96.37%1.95M

-37.00%31.53M

-14.06%42.91M

24.31%50.86M

16.92%194.62M

35.28%53.73M

24.55%50.05M

32.43%49.92M

-16.24%40.92M

Selling and administrative expenses

-41.85%30.84M

-92.35%1.06M

-39.34%7.3M

-28.47%9.91M

-5.11%12.56M

5.34%53.03M

-1.40%13.9M

0.49%12.04M

19.39%13.85M

4.55%13.24M

-General and administrative expense

-41.85%30.84M

-92.35%1.06M

-39.34%7.3M

-28.47%9.91M

-5.11%12.56M

5.34%53.03M

-1.40%13.9M

0.49%12.04M

19.39%13.85M

4.55%13.24M

Research and development costs

-31.90%96.41M

-97.77%888K

-36.26%24.23M

-8.52%33M

38.38%38.3M

21.95%141.59M

55.47%39.82M

34.76%38.01M

38.23%36.07M

-23.51%27.68M

Operating profit

34.62%-127.25M

96.37%-1.95M

37.00%-31.53M

14.06%-42.91M

-24.31%-50.86M

-16.92%-194.62M

-35.28%-53.73M

-24.55%-50.05M

-32.43%-49.92M

16.24%-40.92M

Net non-operating interest income expense

52.01%-3.04M

176.26%1.26M

20.38%-1.34M

-6.92%-1.38M

8.19%-1.58M

-161.57%-6.34M

-47.05%-1.65M

-77.50%-1.69M

-207.66%-1.29M

-2,790.63%-1.72M

Non-operating interest income

800.00%819K

675.00%124K

1,604.35%392K

880.77%255K

84.62%48K

-94.83%91K

-79.49%16K

-89.69%23K

-93.66%26K

-97.52%26K

Non-operating interest expense

-39.96%3.86M

-168.07%-1.13M

1.46%1.74M

24.24%1.63M

-6.81%1.63M

53.74%6.43M

38.81%1.66M

45.74%1.71M

58.45%1.31M

77.46%1.75M

Other net income (expense)

-1,219.06%-49.37M

-5,608.50%-19.45M

-1,202.50%-30M

-96.11%40K

-89.97%31K

286.34%4.41M

18.86%353K

858.10%2.72M

294.25%1.03M

3.00%309K

Special income (charges)

---51.2M

---21.15M

---30.05M

----

--0

----

-Less：Restructuring and merger&acquisition

--51.2M

--21.15M

--30.05M

----

--0

----

Other non- operating income (expenses)

-58.66%1.82M

381.59%1.7M

-98.05%53K

-96.11%40K

-89.97%31K

286.34%4.41M

18.86%353K

858.10%2.72M

294.25%1.03M

3.00%309K

Income before tax

8.59%-179.67M

63.40%-20.14M

-28.27%-62.87M

11.84%-44.24M

-23.82%-52.41M

-17.18%-196.55M

-35.72%-55.02M

-19.98%-49.02M

-32.56%-50.18M

12.70%-42.33M

Income tax

Net income

8.59%-179.67M

63.40%-20.14M

-28.27%-62.87M

11.84%-44.24M

-23.82%-52.41M

-17.18%-196.55M

-35.72%-55.02M

-19.98%-49.02M

-32.56%-50.18M

12.70%-42.33M

Net income continuous Operations

8.59%-179.67M

63.40%-20.14M

-28.27%-62.87M

11.84%-44.24M

-23.82%-52.41M

-17.18%-196.55M

-35.72%-55.02M

-19.98%-49.02M

-32.56%-50.18M

12.70%-42.33M

Minority interest income

Net income attributable to the parent company

8.59%-179.67M

63.40%-20.14M

-28.27%-62.87M

11.84%-44.24M

-23.82%-52.41M

-17.18%-196.55M

-35.72%-55.02M

-19.98%-49.02M

-32.56%-50.18M

12.70%-42.33M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

8.59%-179.67M

63.40%-20.14M

-28.27%-62.87M

11.84%-44.24M

-23.82%-52.41M

-17.18%-196.55M

-35.72%-55.02M

-19.98%-49.02M

-32.56%-50.18M

12.70%-42.33M

Basic earnings per share

10.76%-1.99

63.93%-0.22

-27.27%-0.7

12.50%-0.49

-13.73%-0.58

-7.21%-2.23

-22.00%-0.61

-7.84%-0.55

-19.15%-0.56

15.00%-0.51

Diluted earnings per share

10.76%-1.99

63.93%-0.22

-27.27%-0.7

12.50%-0.49

-13.73%-0.58

-7.21%-2.23

-22.00%-0.61

-7.84%-0.55

-19.15%-0.56

15.00%-0.51

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-34.62%127.25M	-96.37%1.95M	-37.00%31.53M	-14.06%42.91M	24.31%50.86M	16.92%194.62M	35.28%53.73M	24.55%50.05M	32.43%49.92M	-16.24%40.92M
Selling and administrative expenses	-41.85%30.84M	-92.35%1.06M	-39.34%7.3M	-28.47%9.91M	-5.11%12.56M	5.34%53.03M	-1.40%13.9M	0.49%12.04M	19.39%13.85M	4.55%13.24M
-General and administrative expense	-41.85%30.84M	-92.35%1.06M	-39.34%7.3M	-28.47%9.91M	-5.11%12.56M	5.34%53.03M	-1.40%13.9M	0.49%12.04M	19.39%13.85M	4.55%13.24M
Research and development costs	-31.90%96.41M	-97.77%888K	-36.26%24.23M	-8.52%33M	38.38%38.3M	21.95%141.59M	55.47%39.82M	34.76%38.01M	38.23%36.07M	-23.51%27.68M
Operating profit	34.62%-127.25M	96.37%-1.95M	37.00%-31.53M	14.06%-42.91M	-24.31%-50.86M	-16.92%-194.62M	-35.28%-53.73M	-24.55%-50.05M	-32.43%-49.92M	16.24%-40.92M
Net non-operating interest income expense	52.01%-3.04M	176.26%1.26M	20.38%-1.34M	-6.92%-1.38M	8.19%-1.58M	-161.57%-6.34M	-47.05%-1.65M	-77.50%-1.69M	-207.66%-1.29M	-2,790.63%-1.72M
Non-operating interest income	800.00%819K	675.00%124K	1,604.35%392K	880.77%255K	84.62%48K	-94.83%91K	-79.49%16K	-89.69%23K	-93.66%26K	-97.52%26K
Non-operating interest expense	-39.96%3.86M	-168.07%-1.13M	1.46%1.74M	24.24%1.63M	-6.81%1.63M	53.74%6.43M	38.81%1.66M	45.74%1.71M	58.45%1.31M	77.46%1.75M
Other net income (expense)	-1,219.06%-49.37M	-5,608.50%-19.45M	-1,202.50%-30M	-96.11%40K	-89.97%31K	286.34%4.41M	18.86%353K	858.10%2.72M	294.25%1.03M	3.00%309K
Special income (charges)	---51.2M	---21.15M	---30.05M	----	----	--0	--0	--0	----	----
-Less：Restructuring and merger&acquisition	--51.2M	--21.15M	--30.05M	----	----	--0	--0	--0	----	----
Other non- operating income (expenses)	-58.66%1.82M	381.59%1.7M	-98.05%53K	-96.11%40K	-89.97%31K	286.34%4.41M	18.86%353K	858.10%2.72M	294.25%1.03M	3.00%309K
Income before tax	8.59%-179.67M	63.40%-20.14M	-28.27%-62.87M	11.84%-44.24M	-23.82%-52.41M	-17.18%-196.55M	-35.72%-55.02M	-19.98%-49.02M	-32.56%-50.18M	12.70%-42.33M
Income tax
Net income	8.59%-179.67M	63.40%-20.14M	-28.27%-62.87M	11.84%-44.24M	-23.82%-52.41M	-17.18%-196.55M	-35.72%-55.02M	-19.98%-49.02M	-32.56%-50.18M	12.70%-42.33M
Net income continuous Operations	8.59%-179.67M	63.40%-20.14M	-28.27%-62.87M	11.84%-44.24M	-23.82%-52.41M	-17.18%-196.55M	-35.72%-55.02M	-19.98%-49.02M	-32.56%-50.18M	12.70%-42.33M
Minority interest income
Net income attributable to the parent company	8.59%-179.67M	63.40%-20.14M	-28.27%-62.87M	11.84%-44.24M	-23.82%-52.41M	-17.18%-196.55M	-35.72%-55.02M	-19.98%-49.02M	-32.56%-50.18M	12.70%-42.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	8.59%-179.67M	63.40%-20.14M	-28.27%-62.87M	11.84%-44.24M	-23.82%-52.41M	-17.18%-196.55M	-35.72%-55.02M	-19.98%-49.02M	-32.56%-50.18M	12.70%-42.33M
Basic earnings per share	10.76%-1.99	63.93%-0.22	-27.27%-0.7	12.50%-0.49	-13.73%-0.58	-7.21%-2.23	-22.00%-0.61	-7.84%-0.55	-19.15%-0.56	15.00%-0.51
Diluted earnings per share	10.76%-1.99	63.93%-0.22	-27.27%-0.7	12.50%-0.49	-13.73%-0.58	-7.21%-2.23	-22.00%-0.61	-7.84%-0.55	-19.15%-0.56	15.00%-0.51
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall